ALGERT GLOBAL LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$1,768
-11.1%
324,445
+9.5%
0.08%
-4.6%
Q2 2023$1,988
-39.0%
296,245
-19.7%
0.09%
-43.5%
Q1 2023$3,258
+45.8%
368,995
+26.2%
0.15%
+24.2%
Q4 2022$2,234
-99.9%
292,357
+25.1%
0.12%
+22.8%
Q3 2022$1,664,000
-29.5%
233,748
-19.8%
0.10%
-42.9%
Q2 2022$2,359,000
+54.6%
291,535
+165.1%
0.18%
+77.0%
Q1 2022$1,526,000109,9760.10%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders